Nachrichten zur Roivant Sciences Ltd. Aktie

Roivant Sciences Ltd. (ROIV)  (i.) operiert nach einem ungewöhnlichen und hochgradig agilen Geschäftsmodell in der Biotechnologiebranche. Anstatt als einzelner, starrer Großkonzern aufzutreten,...…

…

BASEL, Switzerland and VANCOUVER, British Columbia, March 03, 2026 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid…

Roivant Sciences receives FDA priority review for dermatomyositis drug…

…

Roivant Sciences director Gold sells $26.3 million in shares…

Roivant Sciences stock hits all-time high at 16.8 USD…

Roivant Sciences president Venker sells $25.5m in shares…

Does Roivant Sciences Ltd. (ROIV) have what it takes to be a top stock pick for momentum investors? Lets find…

…

…

…

BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a…

In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than…

…

…

…

…

…

…

…

…

…

Montes Archimedes Acquisition (ROIV) delivered earnings and revenue surprises of 8% and 10.86%, respectively, for the quarter ended March 2024.…

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Jefferies & Co: Michael Yee, Analyst von Jefferies & Co, rät in einer aktuellen Aktienanalyse…

…

Roivant Sciences stock target raised to $16 by Goldman Sachs…